Cargando…

Rational Design, Synthesis and Preliminary Evaluation of Novel Fusarinine C-Based Chelators for Radiolabeling with Zirconium-89

Fusarinine C (FSC) has recently been shown to be a promising and novel chelator for (89)Zr. Here, FSC has been further derivatized to optimize the complexation properties of FSC-based chelators for (89)Zr-labeling by introducing additional carboxylic groups. These were expected to improve the stabil...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhai, Chuangyan, He, Shanzhen, Ye, Yunjie, Rangger, Christine, Kaeopookum, Piriya, Summer, Dominik, Haas, Hubertus, Kremser, Leopold, Lindner, Herbert, Foster, Julie, Sosabowski, Jane, Decristoforo, Clemens
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6468543/ https://www.ncbi.nlm.nih.gov/pubmed/30845658 http://dx.doi.org/10.3390/biom9030091

Ejemplares similares

Fusarinine C, a novel siderophore‐based bifunctional chelator for radiolabeling with Gallium‐68
por: Zhai, Chuangyan, et al.
Publicado: (2015)

Hybrid Imaging Agents for Pretargeting Applications Based on Fusarinine C—Proof of Concept
por: Summer, Dominik, et al.
Publicado: (2020)

Novel Bifunctional Cyclic Chelator for (89)Zr Labeling–Radiolabeling and Targeting Properties of RGD Conjugates
por: Zhai, Chuangyan, et al.
Publicado: (2015)

[(68)Ga]FSC-(RGD)(3) a trimeric RGD peptide for imaging α(v)β(3) integrin expression based on a novel siderophore derived chelating scaffold—synthesis and evaluation
por: Knetsch, Peter A., et al.
Publicado: (2015)

Cholecystokinin-2 Receptor Targeting with Novel C-terminally Stabilized HYNIC-Minigastrin Analogs Radiolabeled with Technetium-99m
por: Klingler, Maximilian, et al.
Publicado: (2019)

Comparison of Ga-68-Labeled Fusarinine C-Based Multivalent RGD Conjugates and [(68)Ga]NODAGA-RGD—In Vivo Imaging Studies in Human Xenograft Tumors
por: Zhai, Chuangyan, et al.
Publicado: (2016)

Exploiting the Concept of Multivalency with (68)Ga- and (89)Zr-Labelled Fusarinine C-Minigastrin Bioconjugates for Targeting CCK2R Expression
por: Summer, Dominik, et al.
Publicado: (2018)

Correction: Klingler, M., et al. Cholecystokinin-2 Receptor Targeting with Novel C-terminally Stabilized HYNIC-Minigastrin Analogs Radiolabeled with Technetium-99m. Pharmaceuticals 2019, 12, 13
por: Klingler, Maximilian, et al.
Publicado: (2019)

Developing Targeted Hybrid Imaging Probes by Chelator Scaffolding
por: Summer, Dominik, et al.
Publicado: (2017)

Recent Advances in Zirconium-89 Chelator Development
por: Bhatt, Nikunj B., et al.
Publicado: (2018)

The Race for Hydroxamate-Based Zirconium-89 Chelators
por: Feiner, Irene V. J., et al.
Publicado: (2021)

Heptadentate chelates for (89)Zr-radiolabelling of monoclonal antibodies
por: Guillou, Amaury, et al.
Publicado: (2022)

Evaluation of macrocyclic hydroxyisophthalamide ligands as chelators for zirconium-89
por: Bhatt, Nikunj B., et al.
Publicado: (2017)

p-Isothiocyanatobenzyl-desferrioxamine: a new bifunctional chelate for facile radiolabeling of monoclonal antibodies with zirconium-89 for immuno-PET imaging
por: Perk, Lars R., et al.
Publicado: (2009)

Modifying the Siderophore Triacetylfusarinine C for Molecular Imaging of Fungal Infection
por: Kaeopookum, Piriya, et al.
Publicado: (2019)

Uptake of the Siderophore Triacetylfusarinine C, but Not Fusarinine C, Is Crucial for Virulence of Aspergillus fumigatus
por: Aguiar, Mario, et al.
Publicado: (2022)

Novel Chelating Agents for Zirconium-89-Positron Emission Tomography (PET) Imaging: Synthesis, DFT Calculation, Radiolabeling, and In Vitro and In Vivo Complex Stability
por: Kang, Chi Soo, et al.
Publicado: (2022)

In Vitro and In Vivo Comparison of Selected Ga-68 and Zr-89 Labelled Siderophores
por: Petrik, Milos, et al.
Publicado: (2015)

Multimerization results in formation of re-bindable metabolites: A proof of concept study with FSC-based minigastrin imaging probes targeting CCK2R expression
por: Summer, Dominik, et al.
Publicado: (2018)

Influence of PEGylation and RGD loading on the targeting properties of radiolabeled liposomal nanoparticles
por: Rangger, Christine, et al.
Publicado: (2012)

Promising Performance of 4HMS, a New Zirconium-89 Octadendate Chelator
por: Alnahwi, Aiman H., et al.
Publicado: (2020)

Hybrid Imaging of Aspergillus fumigatus Pulmonary Infection with Fluorescent, (68)Ga-Labelled Siderophores
por: Pfister, Joachim, et al.
Publicado: (2020)

A new technique for the radiolabelling of mixed leukocytes with zirconium‐89 for inflammation imaging with positron emission tomography
por: Fairclough, M., et al.
Publicado: (2016)

In Vivo Integrity and Biological Fate of Chelator-Free Zirconium-89-Labeled Mesoporous Silica Nanoparticles
por: Chen, Feng, et al.
Publicado: (2015)

Engineering Intrinsically Zirconium‐89 Radiolabeled Self‐Destructing Mesoporous Silica Nanostructures for In Vivo Biodistribution and Tumor Targeting Studies
por: Goel, Shreya, et al.
Publicado: (2016)

On the Versatility of Nanozeolite Linde Type L for Biomedical Applications: Zirconium-89 Radiolabeling and In Vivo Positron Emission Tomography Study
por: Lacerda, Sara, et al.
Publicado: (2022)

From preclinical development to clinical application: Kit formulation for radiolabelling the minigastrin analogue CP04 with In-111 for a first-in-human clinical trial
por: Pawlak, Dariusz, et al.
Publicado: (2016)

Alternative Chelator for (89)Zr Radiopharmaceuticals: Radiolabeling and Evaluation of 3,4,3-(LI-1,2-HOPO)
por: Deri, Melissa A., et al.
Publicado: (2014)

Site-specific stabilization of minigastrin analogs against enzymatic degradation for enhanced cholecystokinin-2 receptor targeting
por: Klingler, Maximilian, et al.
Publicado: (2018)

Site-specific stabilization of minigastrin analogs against enzymatic degradation for enhanced cholecystokinin-2 receptor targeting: Erratum
por: Klingler, Maximilian, et al.
Publicado: (2019)

Influence of a novel, versatile bifunctional chelator on theranostic properties of a minigastrin analogue
por: Pfister, Joachim, et al.
Publicado: (2015)

In Vitro and In Vivo Comparison of 3,2-HOPO Versus Deferoxamine-Based Chelation of Zirconium-89 to the Antimesothelin Antibody Anetumab
por: Roy, Jyoti, et al.
Publicado: (2021)

Tumor targeting and imaging with dual-peptide conjugated multifunctional liposomal nanoparticles
por: Rangger, Christine, et al.
Publicado: (2013)

Cyclic versus Noncyclic Chelating Scaffold for (89)Zr-Labeled ZEGFR:2377 Affibody Bioconjugates Targeting Epidermal Growth Factor Receptor Overexpression
por: Summer, Dominik, et al.
Publicado: (2017)

Siderophores for molecular imaging applications
por: Petrik, Milos, et al.
Publicado: (2016)

A Brief Review of Chelators for Radiolabeling Oligomers
por: Liu, Yuxia, et al.
Publicado: (2010)

Immuno-PET imaging of tumor-infiltrating lymphocytes using zirconium-89 radiolabeled anti-CD3 antibody in immune-competent mice bearing syngeneic tumors
por: Beckford Vera, Denis R., et al.
Publicado: (2018)

Radiolabelled Peptides for Positron Emission Tomography and Endoradiotherapy in Oncology †
por: Rangger, Christine, et al.
Publicado: (2020)

Radiolabelled peptides for oncological diagnosis
por: Laverman, Peter, et al.
Publicado: (2012)

Selection of the First (99m)Tc-Labelled Somatostatin Receptor Subtype 2 Antagonist for Clinical Translation—Preclinical Assessment of Two Optimized Candidates
por: Fani, Melpomeni, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_e516i87349jrtm3oj2l3rnv08k